Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.024 | 0.7 |